会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • Fanc gene mutations in cancer
    • Fanc基因突变在癌症
    • US20060183122A1
    • 2006-08-17
    • US10540904
    • 2003-12-26
    • Scott KernMichael Van Der Heijden
    • Scott KernMichael Van Der Heijden
    • C12Q1/68
    • C07K14/47C12Q1/6886C12Q2600/106C12Q2600/136C12Q2600/156
    • The present invention relates to methods of determining if a patient has cancer or is at increased risk of developing cancer, particularly pancreatic cancer, the method comprising testing a FANC gene for the presence of a cancer-associated coding change, wherein said presence of one or more cancer-associated coding changes is indicative of cancer or an increased risk of cancer in said patient. The invention further relates to methods of treating a patient having cancer, particularly pancreatic cancer, who has one or more cancer-associated coding changes in the FANC genes comprising the step of administering a therapeutically effective amount of a chemotherapeutic cross-linking agent.
    • 本发明涉及确定患者是否患有癌症或具有发展为癌症,特别是胰腺癌的风险增加的方法,所述方法包括测试FANC基因以存在癌症相关编码变化,其中所述存在一种或多种 更多的癌症相关的编码变化是所述患者中的癌症或增加的癌症风险的指示。 本发明还涉及治疗患有癌症的患者,特别是胰腺癌的方法,所述患者在FANC基因中具有一种或多种与癌症相关的编码变化,包括给予治疗有效量的化学治疗性交联剂的步骤。